How to Know When Your Blood Sugar Is Low: Warning Signs and Solutions

What Counts as Low Blood Sugar

The American Diabetes Association defines hypoglycemia as any glucose reading below 70 mg/dL (3.9 mmol/L), and uses a three-tier classification system that guides both urgency and treatment intensity 1. Level 1 covers readings between 54 and 70 mg/dL. Level 2 starts below 54 mg/dL and signals clinically significant risk. Level 3 describes any episode severe enough to require help from another person 2.

This tiered system exists because consequences scale with depth. A 2018 analysis in Diabetes Care found that glucose levels below 54 mg/dL were associated with a 2.3-fold increase in cardiovascular events over 3.9 years of follow-up 3. Repeated episodes below that threshold also accelerate cognitive decline, particularly in older adults with type 2 diabetes 4.

For people without diabetes, true hypoglycemia is uncommon. The Endocrine Society diagnostic criteria require documented low glucose concurrent with symptoms that resolve when glucose is corrected (Whipple's triad) 5. Reactive hypoglycemia after meals can produce similar symptoms but rarely drops glucose below 55 mg/dL.

Early Warning Signs Your Body Sends

The earliest symptoms come from the autonomic nervous system firing in response to falling glucose. Your adrenal glands release epinephrine, which produces a predictable set of physical signals 6. Shakiness, sweating, heart pounding, and sudden intense hunger are the hallmarks. These typically appear at glucose levels around 65 to 70 mg/dL and serve as a built-in alarm system.

Anxiety and irritability also belong to this early-warning category. A study published in the Journal of Clinical Endocrinology & Metabolism documented that epinephrine release during mild hypoglycemia produces measurable increases in anxiety scores, even in healthy volunteers 7. Tingling or numbness around the lips and fingertips may also appear at this stage.

The speed of the glucose drop matters as much as the absolute number. A person whose blood sugar falls from 180 to 90 mg/dL in under an hour may experience these autonomic symptoms even though 90 mg/dL is technically normal 8. This phenomenon of "relative hypoglycemia" is well-documented in people with chronically elevated averages. The body recalibrates its alarm threshold upward.

Severe Symptoms That Demand Immediate Action

When glucose falls below 54 mg/dL, neuroglycopenic symptoms emerge. The brain, which consumes roughly 120 grams of glucose daily and cannot store meaningful reserves, begins to malfunction 9. Confusion, slurred speech, difficulty concentrating, and loss of coordination signal that cerebral function is compromised.

Visual disturbances follow. Blurred or double vision occurs because the visual cortex is exquisitely sensitive to glucose deprivation 10. Behavioral changes such as combativeness, crying, or acting intoxicated are common and frequently misinterpreted by bystanders. Below 40 mg/dL, seizures and loss of consciousness become real risks.

Severe hypoglycemia carries measurable danger. The NICE-SUGAR trial (N=6,104) demonstrated that intensive glucose control resulting in more frequent severe hypoglycemia was associated with a 14% increase in 90-day mortality among ICU patients 11. The ACCORD trial (N=10,251) similarly found that severe hypoglycemia was associated with increased mortality in the intensive-treatment arm 12. These findings reshaped how aggressively clinicians target glucose in high-risk populations.

Hypoglycemia Unawareness: The Hidden Danger

Some people lose the ability to sense dropping glucose. This is called hypoglycemia unawareness, and it affects approximately 20 to 25% of people with type 1 diabetes and 10% of insulin-treated type 2 diabetes patients 13. The autonomic warning system becomes blunted after repeated episodes, creating a vicious cycle: frequent lows suppress the hormonal response, removing the early alarms, which leads to more severe lows.

A landmark study by Cryer and colleagues demonstrated that just two episodes of mild hypoglycemia (55 mg/dL) on consecutive days was sufficient to blunt the epinephrine and symptom responses during a subsequent episode 14. The good news: strict avoidance of hypoglycemia for 2 to 3 weeks can partially restore awareness in many patients, a process called "hypoglycemia awareness recovery" 15.

Continuous glucose monitoring (CGM) has become the primary clinical tool to address this problem. The IMPACT trial showed that FreeStyle Libre use reduced time in hypoglycemia (below 70 mg/dL) by 38% compared to fingerstick monitoring alone 16. The HypoDE trial found CGM reduced the number of hypoglycemic events below 54 mg/dL by 72% in patients with hypoglycemia unawareness 17.

Common Causes of Low Blood Sugar

Insulin and insulin secretagogues (sulfonylureas like glipizide, glyburide) account for the vast majority of hypoglycemia cases. The ADA Standards of Care lists sulfonylureas as carrying significantly higher hypoglycemia risk compared to newer agents like SGLT2 inhibitors or GLP-1 receptor agonists 1. Among insulin regimens, basal-bolus therapy carries more risk than basal-only protocols, and rapid-acting analogs carry less risk than regular human insulin 18.

Beyond medications, several patterns trigger drops:

Skipped or delayed meals after taking insulin or sulfonylureas is the most common behavioral cause. Exercise amplifies the effect. A single bout of moderate-intensity exercise (60 minutes of cycling at 50% VO2 max) can increase insulin sensitivity for up to 48 hours after the session, creating a delayed hypoglycemia window 19.

Alcohol consumption suppresses hepatic glucose output by inhibiting gluconeogenesis. The effect is dose-dependent and can persist for 12 to 16 hours after last drink 20. Drinking on an empty stomach while taking insulin is a high-risk combination.

Renal impairment reduces insulin clearance, effectively extending its duration of action. The KDIGO guidelines note that patients with eGFR below 30 mL/min require insulin dose reductions of 25 to 50% 21.

Non-diabetic causes include insulinoma (rare, ~4 per million per year), adrenal insufficiency, critical illness, and certain medications including quinine and pentamidine 5.

How to Treat a Low Blood Sugar Episode

The "Rule of 15" is the standard first-response protocol endorsed by the ADA: consume 15 grams of fast-acting carbohydrate, wait 15 minutes, recheck glucose, and repeat if still below 70 mg/dL 1. Sources of 15 grams include 4 glucose tablets, 4 oz (120 mL) regular juice, or 1 tablespoon of sugar dissolved in water.

Glucose tablets raise blood sugar faster than food. A pharmacokinetic comparison showed glucose tablets produced a mean rise of 38 mg/dL in 15 minutes versus 25 mg/dL for orange juice 22. Avoid treating with chocolate, cookies, or other high-fat foods. Fat slows gastric emptying and delays glucose absorption.

For severe episodes where the person cannot swallow safely, glucagon is the treatment. Three FDA-approved formulations exist: Eli Lilly's Glucagon Emergency Kit (intramuscular injection), Baqsimi (nasal glucagon, 3 mg single-dose), and Gvoke HypoPen (ready-to-use subcutaneous auto-injector) 23. Baqsimi's nasal delivery was shown to be non-inferior to injected glucagon in a randomized trial, with successful glucose recovery in 98.7% of episodes 24.

After any severe episode, the person should eat a substantial mixed meal once they are alert and able to swallow. A follow-up call to their prescribing clinician is warranted to adjust the regimen that caused the event.

Preventing Future Episodes

Prevention is a medication and monitoring conversation, not just a food-timing strategy. The Endocrine Society recommends structured glucose monitoring with individualized glycemic targets as the foundation of prevention 5.

Medication adjustment is the highest-yield intervention. Switching from sulfonylureas to DPP-4 inhibitors or GLP-1 receptor agonists reduces hypoglycemia risk substantially. The LEADER trial (N=9,340) documented severe hypoglycemia rates of 2.4% with liraglutide versus 3.3% with placebo over 3.8 years, even with greater glucose lowering in the liraglutide group 25. For type 1 diabetes, hybrid closed-loop insulin pump systems reduce time below 70 mg/dL by approximately 50% compared to standard pump therapy 26.

Pre-exercise planning prevents activity-related drops. The ADA's consensus report on exercise in diabetes recommends consuming 15, 30 grams of carbohydrate before moderate activity if pre-exercise glucose is below 126 mg/dL 27. Reducing bolus insulin by 25 to 75% for meals preceding exercise is another validated approach.

Bedtime snacks with a mix of complex carbohydrate and protein (example: peanut butter on whole-grain crackers) may reduce nocturnal hypoglycemia risk, though evidence from randomized trials is limited 28. CGM with low-glucose alarms provides more reliable overnight protection.

When to See a Doctor About Low Blood Sugar

Any person without diabetes who experiences documented glucose below 55 mg/dL with concurrent symptoms should undergo a diagnostic workup. The Endocrine Society guideline recommends a supervised 72-hour fast with serial glucose, insulin, C-peptide, and proinsulin measurements to rule out insulinoma and other causes of endogenous hyperinsulinism 5.

For people with diabetes, the threshold for clinical reassessment is lower. The ADA recommends revisiting the treatment plan after any Level 2 episode (glucose below 54 mg/dL) and mandates it after any Level 3 episode 1. Recurrent Level 1 hypoglycemia (two or more episodes per week) also warrants a medication review.

Dr. Philip Cryer, a leading hypoglycemia researcher at Washington University School of Medicine, has stated: "Iatrogenic hypoglycemia is the limiting factor in the glycemic management of diabetes. It causes recurrent morbidity, and sometimes death, in people with type 1 and advanced type 2 diabetes" 29.

Dr. Pratik Choudhary of King's College London has noted: "Impaired awareness of hypoglycaemia remains one of the most dangerous complications of insulin therapy, and restoring awareness should be a clinical priority" 30.

Blood Sugar Monitoring Tools and Technology

Fingerstick glucose meters remain the most accessible monitoring option, with an accuracy requirement of ±15% at glucose levels above 100 mg/dL and ±15 mg/dL below 100 mg/dL per FDA standards 31. For detecting hypoglycemia specifically, modern meters have mean absolute relative difference (MARD) values between 5% and 10%, meaning readings at 60 mg/dL could vary by 3 to 6 mg/dL.

CGM technology has transformed hypoglycemia detection. The Dexcom G7 and FreeStyle Libre 3 both report MARD values below 9% and provide real-time alerts when glucose drops below user-set thresholds 32. The ability to see glucose trends (falling, stable, rising) gives users 10 to 30 minutes of advance warning before reaching hypoglycemic levels.

For those with hypoglycemia unawareness, CGM is no longer optional. It is the standard of care. The 2024 ADA Standards of Care recommends CGM for all adults with type 1 diabetes and for adults with type 2 diabetes on multiple daily insulin injections who are at risk for hypoglycemia 1.